News
Although ‘lean type 2 diabetes’ is not uncommon, clinicians must first exclude other causes including autoimmune, monogenic, ...
A new indication for omalizumab is prompting clinicians to adjust their approach to oral food challenges, but experts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results